Tonix Pharmaceuticals Holding CORP. (TNXP) — SEC Filings

Overview

Tonix Pharmaceuticals Holding CORP. (TNXP) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Mar 31, 2026: Tonix Pharmaceuticals Holding Corp. filed an 8-K on March 31, 2026, reporting on events from March 30, 2026. The filing includes a press release and corporate presentations, indicating potential new information or updates being shared with the public. Specific details regarding the content of these

Sentiment Summary

Across 50 filings, the sentiment breakdown is: 1 bearish, 48 neutral, 1 mixed. The dominant filing sentiment for Tonix Pharmaceuticals Holding CORP. is neutral.

Filing Type Overview

Tonix Pharmaceuticals Holding CORP. (TNXP) has filed 45 8-K, 3 10-Q, 1 DEF 14A, 1 10-K with the SEC between Dec 2024 to Mar 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (50)

• Tonix Pharmaceuticals Files 8-K with Presentations — 8-K · Mar 31, 2026 Risk: medium
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on March 31, 2026, reporting on events from March 30, 2026. The filing includes a press release and corporate p
• 8-K Filing — 8-K · Dec 29, 2025
• 8-K Filing — 8-K · Dec 16, 2025
• Tonix Pharma Files 8-K on Dec 9, 2025 — 8-K · Dec 9, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on December 9, 2025, reporting on events including a Regulation FD Disclosure, Other Events, and Financial Stat
• Tonix Pharmaceuticals Files 8-K — 8-K · Nov 24, 2025 Risk: low
  On November 24, 2025, Tonix Pharmaceuticals Holding Corp. filed an 8-K report. The filing indicates a Regulation FD Disclosure and Other Events. The company's p
• 8-K Filing — 8-K · Nov 21, 2025
• 8-K Filing — 8-K · Nov 18, 2025
• Tonix Pharmaceuticals Files 8-K — 8-K · Nov 17, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on November 17, 2025, reporting on other events and financial statements. The filing does not disclose specific
• Tonix Pharma's Losses Widen Amid Tonmya Launch Prep, Cash Reserves Grow — 10-Q · Nov 10, 2025 Risk: high
  Tonix Pharmaceuticals Holding Corp. (TNXP) reported a net loss of $32.01 million for the three months ended September 30, 2025, a significant increase from the
• Tonix Pharma Files 8-K on Operations and Other Events — 8-K · Oct 27, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on October 27, 2025, reporting on its results of operations and financial condition, as well as other events. T
• Tonix Pharmaceuticals Files 8-K — 8-K · Oct 22, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on October 22, 2025, reporting on other events and financial statements. The filing indicates the company's pri
• Tonix Pharmaceuticals Files 8-K — 8-K · Oct 7, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on October 7, 2025, reporting on various events. The filing includes information related to financial statement
• Tonix Pharmaceuticals Files 8-K on Sept 30, 2025 — 8-K · Sep 30, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on September 30, 2025, reporting on events including a Regulation FD Disclosure, Other Events, and Financial St
• Tonix Pharmaceuticals Files 8-K — 8-K · Sep 29, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on September 29, 2025, reporting on other events and financial statements. The company, incorporated in Nevada,
• Tonix Pharmaceuticals Files 8-K — 8-K · Sep 18, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on September 18, 2025, reporting on other events and financial statements. The company, incorporated in Nevada,
• Tonix Pharmaceuticals Files 8-K — 8-K · Sep 17, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on September 17, 2025, reporting on other events and financial statements. The filing indicates the company's p
• Tonix Pharmaceuticals Files 8-K — 8-K · Aug 18, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on August 18, 2025, reporting on other events and financial statements. The filing details the company's princi
• Tonix Pharmaceuticals Files 8-K — 8-K · Aug 15, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on August 15, 2025, reporting on events that occurred on the same date. The filing indicates it is a current re
• Tonix Pharma's Q2 Loss Widens to $19.5M Amid Soaring R&D Costs — 10-Q · Aug 11, 2025 Risk: high
  Tonix Pharmaceuticals Holding Corp. reported no revenue for the three and six months ended June 30, 2025, consistent with its pre-commercial stage. The company
• Tonix Pharmaceuticals Files 8-K — 8-K · Jul 25, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on July 25, 2025, reporting on its results of operations and other events. The filing does not contain specific
• Tonix Pharmaceuticals Files 8-K — 8-K · Jul 21, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on July 21, 2025, reporting on other events and financial statements. The filing does not contain specific fina
• Tonix Pharmaceuticals Files 8-K — 8-K · Jul 16, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on July 16, 2025, reporting on other events and financial statements. The filing details the company's corporat
• Tonix Pharmaceuticals Files 8-K — 8-K · Jul 10, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on July 10, 2025, reporting on other events and financial statements. The company, incorporated in Nevada, is b
• Tonix Pharmaceuticals Relocates Offices, Updates Contact Info — 8-K · Jul 9, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on July 9, 2025, reporting on other events and financial statements. The filing indicates a change in the compa
• Tonix Pharmaceuticals Files 8-K — 8-K · Jul 2, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on July 2, 2025, reporting on other events and financial statements. The filing indicates the company's princip
• Tonix Pharmaceuticals Files 8-K — 8-K · Jun 16, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on June 16, 2025, reporting on other events and financial statements. The filing does not contain specific fina
• Tonix Pharma Files 8-K: Officer/Director Changes & Compensation — 8-K · Jun 13, 2025 Risk: medium
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on June 13, 2025, reporting on events from June 12, 2025. The filing indicates changes in directors or officers
• Tonix Pharmaceuticals Files 8-K with Material Agreement — 8-K · Jun 11, 2025 Risk: medium
  On June 11, 2025, Tonix Pharmaceuticals Holding Corp. filed an 8-K report detailing a material definitive agreement. The filing also includes financial statemen
• Tonix Pharmaceuticals Files 8-K — 8-K · May 21, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on May 21, 2025, reporting on other events and financial statements. The filing does not disclose specific new
• Tonix Pharmaceuticals Files 8-K — 8-K · May 14, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on May 14, 2025, reporting on various events. The filing includes information related to Regulation FD Disclosu
• Tonix Pharmaceuticals Files Q1 2025 10-Q — 10-Q · May 12, 2025 Risk: medium
  Tonix Pharmaceuticals Holding Corp. filed its 10-Q for the period ending March 31, 2025. The company reported financial results for the first quarter of 2025, d
• Tonix Pharmaceuticals Files 8-K on Security Holder Vote — 8-K · May 8, 2025 Risk: medium
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on May 8, 2025, reporting on the submission of matters to a vote of security holders. The filing does not conta
• Tonix Pharmaceuticals Files 8-K — 8-K · Apr 29, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on April 29, 2025, to report on various events. The filing includes information related to Regulation FD Disclo
• Tonix Pharmaceuticals Files 8-K — 8-K · Apr 25, 2025 Risk: medium
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on April 25, 2025, reporting on its results of operations and other events. The filing details the company's fi
• Tonix Pharmaceuticals Files 8-K With Exhibits — 8-K · Apr 24, 2025 Risk: low
  On April 23, 2025, Tonix Pharmaceuticals Holding Corp. filed an 8-K report. The filing primarily consists of financial statements and exhibits, with no specific
• Tonix Pharmaceuticals Files 8-K — 8-K · Apr 9, 2025 Risk: medium
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on April 9, 2025, reporting on events including a Regulation FD Disclosure and Other Events. The filing also in
• Tonix Pharmaceuticals Files 8-K — 8-K · Apr 1, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on April 1, 2025, reporting on events including a Regulation FD Disclosure, Other Events, and Financial Stateme
• Tonix Pharma Files 2025 Proxy Statement — DEF 14A · Mar 31, 2025 Risk: medium
  Tonix Pharmaceuticals Holding Corp. filed its DEF 14A proxy statement on March 31, 2025, for the fiscal year ending December 31, 2024. The filing details execut
• 8-K Filing — 8-K · Mar 24, 2025
• Tonix Pharmaceuticals Files 2024 10-K — 10-K · Mar 18, 2025 Risk: medium
  Tonix Pharmaceuticals Holding Corp. filed its 2024 10-K on March 18, 2025, reporting its financial results for the fiscal year ending December 31, 2024. The com
• Tonix Pharmaceuticals Files 8-K — 8-K · Mar 10, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on March 10, 2025, reporting on various events. The filing includes information on financial statements and exh
• 8-K Filing — 8-K · Mar 4, 2025
• Tonix Pharma Files 8-K: Director Changes & Officer Compensation — 8-K · Mar 4, 2025 Risk: medium
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on February 27, 2025, reporting on the departure of directors, election of new directors, and compensatory arra
• Tonix Pharmaceuticals Files 8-K Under 'Other Events' — 8-K · Feb 21, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on February 21, 2025, reporting an event on February 20, 2025. The filing is categorized under 'Other Events' a
• Tonix Pharma Relocates Executive Offices — 8-K · Feb 7, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on February 7, 2025, reporting on events that occurred on the same date. The filing indicates a change in the c
• Tonix Pharmaceuticals Files 8-K — 8-K · Feb 6, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on February 6, 2025, reporting on its corporate activities. The filing confirms the company's principal executi
• Tonix Pharma Files 8-K on Officer/Director Changes & More — 8-K · Feb 4, 2025 Risk: medium
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on February 4, 2025, reporting events as of February 3, 2025. The filing covers the departure of directors or c
• Tonix Pharmaceuticals Terminates Material Agreement — 8-K · Feb 3, 2025 Risk: medium
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on February 3, 2025, reporting the termination of a material definitive agreement and other events. The filing
• Tonix Pharmaceuticals Files 8-K — 8-K · Jan 8, 2025 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on January 8, 2025, reporting on other events and financial statements. The filing indicates the company's prin
• Tonix Pharmaceuticals Files 8-K — 8-K · Dec 23, 2024 Risk: low
  Tonix Pharmaceuticals Holding Corp. filed an 8-K on December 23, 2024, reporting on other events and financial statements. The filing indicates the company's pr

Related Companies

PFE · LLY · JNJ · TONX

Frequently Asked Questions